More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Human FREE soluble RANKL ELISA
The figure shows a typical standard curve for the human RANKL ELISA kit. The immunoassay is calibrated against recombinant RANKL peptide.
The figure shows a typical standard curve for the human RANKL ELISA kit. The immunoassay is calibrated against recombinant RANKL peptide.
The figure shows a typical standard curve for the human RANKL ELISA kit. The immunoassay is calibrated against recombinant RANKL peptide.

Human FREE soluble RANKL ELISA

Research Use Only
BI-20462
Biomedica
Assay Sample TypeSerum, heparın plasma
DownloadDatasheet
Product group Assays
€ 817,00
96 tests
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    Biomedica
  • Product Name
    Human FREE soluble RANKL ELISA
  • Delivery Days Customer
    7
  • Applications
    ELISA
  • Assay Detection Range
    0 – 2 pmol/l (= 0 – 40 pg/ml)
  • Assay Precision
    In-between-run (n=12): ≤ 3 % CV. Within-run (n=5): ≤ 5 % CV
  • Assay Sample Type
    Serum, heparın plasma
  • Assay Sensitivity
    0.01 pmol/l (= 0.2 pg/ml)
  • Assay Specificity
    Endogenous and recombinant human free soluble RANKL.
  • Assay Test Principle
    The Biomedica RANKL ELISA is a sandwich enzyme immunoassay for the quantitative determination of free soluble RANKL in human serum and heparın plasma samples.
  • Assay Time
    2 h / overnight / 1 h / 30 min
  • Certification
    Research Use Only
  • Scientific Description
    The human RANKL ELISA kit is an overnight, 96-well sandwich ELISA for the quantitative determination of free soluble RANKL in serum and heparın plasma.
  • UNSPSC
    41116133

References

  • Tietze H, Pott V, Kanzelmeyer N, et al. LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (Srankl) and osteoprotegerin (Opg) in the HARP cohort. Osteoporos Int. 2024;35(3):533-542.
    Read more